Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04547439 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Sleep, Diabetic Retinopathy and Melatonin

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date changed from estimate of Dec 2025 to Feb 2, 2026v8
  2. Enrollment target: 36 to 42v7
  3. 3 versions Re-verified since May 16, 2022, no change to tracked fieldsv4-v6
  4. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Jan 2021 to Feb 3, 2021 · Site details revisedv3 Show 2 more changesShow less
    • Start date changed from estimate of Jan 2021 to Feb 3, 2021
    • Site details revised
  5. Re-verified, no change to tracked fieldsv2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study explores the use of melatonin in patients with diabetic retinopathy
Trial Details
NCT Number NCT04547439
Lead Sponsor University of Illinois at Chicago
Collaborators: University of Chicago
Conditions Diabetes Mellitus, Diabetic Retinopathy
Enrollment 42 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov